The healthcare/life sciences community receives integrated data and data-driven insights from precision medicine software (platforms, data-sharing networks, clinical decision support software, AI-enabled, etc.) to boost their precision medicine programme.
Additionally, new molecular strategy introductions are anticipated to fuel the expansion of the global Precision Medicine Software Market. For instance, the Wyss Institute at Harvard unveiled a new molecular approach in April 2018. (NuProbe). A DNA nanotechnology-based variant detection technique is called NuProbe. It is a quick, inexpensive, and multiplexed molecular diagnostic tool used to identify a number of illnesses, such as cancer and infectious disorders.
Read more @ https://creativeedge16.blogspot.com/2022/07/precision-medicine-software-market.html
